Delivery Order SPE2DR25D3103-SPE2DR26F9K22
- Not listed
- The Defense Logistics Agency awarded a $7,748.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. The award represents a non-competitive delivery order issued under an existing indefinite delivery contract vehicle. Performance will be completed by January 6, 2026, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) under a firm fixed-price contract valued at $30,993.56. This competitive award, issued on December 19, 2025, with an ultimate completion date of January 13, 2026, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026....
- The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Erleada 240 mg tablets, with a completion date of November 24, 2025. This non-set-aside, firm fixed-price contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $29,822.56 and is structured under a firm fixed-price arrangement, with an ultimate completion date of October 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) on December 1, 2025, with completion scheduled for December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.79 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) on October 29, 2025, with completion scheduled for November 20, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,748.39 to AmerisourceBergen Drug Corp for 30 units of Erleada 240 mg tablets, a prescription pharmaceutical product. This non-set-aside, firm fixed-price delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,965.80 delivery order to AmerisourceBergen Drug Corp for 120 units of Erleada 60 mg tablets on December 10, 2025, with a completion date of January 2, 2026. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary headquarters and...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $7,748.39 for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 9, 2025. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a leading pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K22Delivery Order
The Defense Logistics Agency awarded a $7,748.39 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company was competitively selected for this delivery order based on its extensive capability to fulfill pharmaceutical supply requirements across multiple therapeutic domains. Through the SPE2DX IDC vehicle, AmerisourceBergen provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, delivering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 11/27/25 |